Overview

Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection

Status:
Not yet recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of using Desferal injections for prevention of ARDS in moderate cases with fever , chest tightness and relevant chest images
Phase:
Phase 4
Details
Lead Sponsor:
Hesham Al-Inany
Treatments:
Deferoxamine